Home » All » Stock Forecast » AbCellera Biologics Inc. Common Shares Forecast

AbCellera Biologics Inc. Common Shares Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▲ +2.05%Market Cap $1.18B · Technical analysis Bullish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$3.95 ▼ -1.06%	Yesterday	$4.01 ▲ +0.45%	Tomorrow's AbCellera Biologics Inc. Common Shares (ABCL) setup is anchored to $3.99 and targets $3.95 (-1.06%). The near-term read is downside; watch $4.11 / $3.87 because daily realized volatility is about 5.47%.
Tomorrow's AbCellera Biologics Inc. Common Shares (ABCL) setup is anchored to $3.99 and targets $3.95 (-1.06%). The near-term read is downside; watch $4.11 / $3.87 because daily realized volatility is about 5.47%.
Week	$3.86 ▼ -3.30%	Last Week	$4.05 ▲ +1.39%	The 7-day AbCellera Biologics Inc. Common Shares model moves from $4.05 to $3.86 (-3.30%). It gives downside momentum context for this stock, so breaks around $4.11 / $3.87 matter more than a single tick.
The 7-day AbCellera Biologics Inc. Common Shares model moves from $4.05 to $3.86 (-3.30%). It gives downside momentum context for this stock, so breaks around $4.11 / $3.87 matter more than a single tick.
Month	$3.71 ▼ -7.03%	Last Month	$4.11 ▲ +2.95%	The 1-month AbCellera Biologics Inc. Common Shares target is $3.71 (-7.03%), compared with the live reference near $3.99. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month AbCellera Biologics Inc. Common Shares target is $3.71 (-7.03%), compared with the live reference near $3.99. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$3.49 ▼ -12.62%	Last Year	$4.20 ▲ +5.30%	The 1-year AbCellera Biologics Inc. Common Shares scenario points to $3.49 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year AbCellera Biologics Inc. Common Shares scenario points to $3.49 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$2.96 ▼ -25.71%	5 Years Ago	$4.42 ▲ +10.80%	The 5-year AbCellera Biologics Inc. Common Shares view is $2.96 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year AbCellera Biologics Inc. Common Shares view is $2.96 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$3.95▼ -1.06%

Yesterday$4.01▲ +0.45%

Tomorrow's AbCellera Biologics Inc. Common Shares (ABCL) setup is anchored to $3.99 and targets $3.95 (-1.06%). The near-term read is downside; watch $4.11 / $3.87 because daily realized volatility is about 5.47%.

Week$3.86▼ -3.30%

Last Week$4.05▲ +1.39%

The 7-day AbCellera Biologics Inc. Common Shares model moves from $4.05 to $3.86 (-3.30%). It gives downside momentum context for this stock, so breaks around $4.11 / $3.87 matter more than a single tick.

Month$3.71▼ -7.03%

Last Month$4.11▲ +2.95%

The 1-month AbCellera Biologics Inc. Common Shares target is $3.71 (-7.03%), compared with the live reference near $3.99. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$3.49▼ -12.62%

Last Year$4.20▲ +5.30%

The 1-year AbCellera Biologics Inc. Common Shares scenario points to $3.49 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$2.96▼ -25.71%

5 Years Ago$4.42▲ +10.80%

The 5-year AbCellera Biologics Inc. Common Shares view is $2.96 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Neutral

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$3.99	Mid
Daily Change	+2.05%	Above
Volatility Cap	20.0%	Mid
Confidence	62%	Below
Data Source	nasdaq-screener	Mid

Historical Data

Current$3.99

Daily Change+2.05%

Market Cap$1.18B

Sourcenasdaq-screener

Current	$3.99	Daily Change	+2.05%
Market Cap	$1.18B	Source	nasdaq-screener

Support & Resistance Levels

$3.87Support 1

$3.99Current

$4.11Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$3.99Live reference price

Used as the anchor for generated forecast calculations.

Next Month$3.71Model projection-7.03%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

62%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

62%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in ABCL today

Bullish Scenario

$4.19

+5.00% from current

Target Price$4.19

ScenarioUpside momentum

Probability54%

Base Scenario

$3.71

-7.03%

Target Price$3.71

ScenarioCapped drift

Probability62%

Bearish Scenario

$3.79

-5.00% from current

Target Price$3.79

ScenarioVolatility drawdown

Probability38%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bearish · 35/100

24H drift-1.06%

7D drift-3.30%

30D drift-7.03%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-Off Caution · 27/100

1M outlook-7.03%

1Y outlook-12.62%

5Y outlook-25.71%

Frequently Asked Questions

Q What is the AbCellera Biologics Inc. Common Shares (ABCL) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), AbCellera Biologics Inc. Common Shares is projected near $3.95 versus the current reference around $3.99. That implies a modeled move of -1.06% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for ABCL?

The weekly AbCellera Biologics Inc. Common Shares model points to $3.86, which maps to an expected drift of -3.30% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the AbCellera Biologics Inc. Common Shares 1-month and 1-year targets?

The AbCellera Biologics Inc. Common Shares 1-month target is $3.71 (-7.03%), while the 1-year target is $3.49 (-12.62%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the AbCellera Biologics Inc. Common Shares 5-year scenario differ from short-term rows?

The AbCellera Biologics Inc. Common Shares long-horizon scenario sits near $2.96 with a modeled change of -25.71%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are ABCL support and resistance zones right now?

For AbCellera Biologics Inc. Common Shares, nearest resistance is around $3.87, while nearest support is around $4.11. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the AbCellera Biologics Inc. Common Shares market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.